Standout Papers

Lebrikizumab Treatment in Adults with Asthma 2007 2026 2013 2019 1.1k
  1. Lebrikizumab Treatment in Adults with Asthma (2011)
    Jonathan Corren, Robert F. Lemanske et al. New England Journal of Medicine
  2. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma (2007)
    Patrick Flood-Page, Cheri A. Swenson et al. American Journal of Respiratory and Critical Care Medicine
  3. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials (2016)
    Nicola A. Hanania, Phillip E. Korenblat et al. The Lancet Respiratory Medicine

Immediate Impact

1 by Nobel laureates 18 from Science/Nature 161 standout
Sub-graph 1 of 13

Citing Papers

Fibrosis: from mechanisms to medicines
2020 StandoutNature
The Cytokines of Asthma
2019 Standout
91 intermediate papers

Works of John G. Matthews being referenced

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2016 Standout
Lebrikizumab Treatment in Adults with Asthma
2011 Standout
and 12 more

Author Peers

Author Last Decade Papers Cites
John G. Matthews 3263 2008 1045 1379 41 4.2k
Mark C. Liu 3215 2132 1099 1378 54 4.7k
I. Enander 3273 2066 1340 930 48 4.1k
Ana R. Sousa 4267 2504 1427 1355 74 5.7k
David F. Choy 3370 2137 853 1837 61 5.5k
Gregory P. Geba 3006 1556 1186 2112 90 5.7k
François-Bernard Michel 2671 1401 1542 727 46 3.5k
Beverley Hargadon 4195 3155 783 1111 35 4.8k
J.V. Collins 2285 1808 591 797 51 3.5k
James Zangrilli 2598 1828 714 969 53 3.4k
Joëlle Simony-Lafontaine 1839 1094 661 641 25 3.4k

All Works

Loading papers...

Rankless by CCL
2026